Nektar Therapeutics
0 sources
Financials
0001193125-26-104547Summary
Nektar Therapeutics is a business[1]. It ranks in the top 4% of business entities by monthly Wikipedia readership (152 views/month).[2]
Key Facts
- Country: United States[3], US[4]
- Instance of: public company[5]
- Headquarters location: San Francisco[6]
- Stock exchange: Nasdaq[7]
- Inception: 1990[8]
- Official website: http://www.nektar.com/[9]
- Product or material produced: Inhalable insulin[10]
- Legal form: 8888[11]
Why It Matters
Nektar Therapeutics is known by 4 alternative names across languages and contexts.[12]